In a drastic move to raise more funds for medical research, Monash University has sold off 6 million of its shares in promising Victorian biotech Metabolic Pharmaceuticals (ASX:MBP). [ + ]

Australia risks being left out in the cold if it doesn't participate in efforts to sequence the marsupial genome, say leading genomics scientists who are trying to raise AUD$5 million in support of Australian participation. [ + ]

Adelaide biotech Bionomics (ASX:BNM, US OTC:BMICV)) has filed a provisional patent application on a DNA diagnostic test for a benign form of epilepsy that causes seizures in early childhood. [ + ]

Scientist at a British company have discovered a way of making the glass plates used in laboratories 200 times more effective.

Sydney's Australian Technology Park biotech hub has grown to nine companies with two new businesses recently joining the BioFirst precinct. [ + ]

Medical device company Polartechnics (ASX:PLT) today announced it had secured commitments to raise $5 million to assist in international marketing of its three core products. [ + ]

A $20,000 investment in the early 1990s has turned into a multi-million-dollar business for Consulting Orthopaedic Surgeon to the Royal Adelaide Hospital, Mr. Tony Ingman, with surgical implant sales to hospitals nationally and exports to China, Europe and the Middle East.

UniQuest Pty Limited, The University of Queensland's main technology commercialisation company, has unveiled the University's first formal technology incubator.

A $20 million plant biotechnology centre to explore ways of improving agricultural sustainability and develop plants resistant to drought, frost and salinity was opened recently at the University of Melbourne.

Brisbane's Progen Industries (ASX:PGL) will take on production of an anti-cancer therapeutic vaccine for Prima Biomed's (ASX:PRR) Cancer Vac subsidiary. [ + ]

Australian researchers have discovered two genes that are critical to understanding elite athletic performance, an Athens conference has heard. [ + ]

Sydney-based Brain Resource Company (ASX:BRC) has cracked into the biotechnology sector with a deal to provide its profiles of brain function and cognition to Biogen in the United States. [ + ]

Diagnostics group Visiomed (ASX:VSG) has entered a German research collaboration to develop surgical navigation systems for spinal procedures. [ + ]

Bone marrow stem cells have been used to treat five patients with severe angina in a Phase I clinical trial at St Vincent's Hospital in Melbourne. [ + ]

Circadian Technologies (ASX:CIR) has added another string to its neuroscience bow with an investment in new Melbourne research. [ + ]